Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vir Biotechnology, Inc.

7.10
-0.2750-3.73%
Volume:628.85K
Turnover:4.45M
Market Cap:973.03M
PE:-1.85
High:7.43
Open:7.37
Low:6.96
Close:7.37
Loading ...

What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday?

Benzinga
·
16 Nov 2024

Vir Biotechnology reports ‘positive’ end-of-treatment data from MARCH study

TIPRANKS
·
16 Nov 2024

Vir Biotechnology Announces Positive End-of-Treatment Results for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B from the MARCH Study at AASLD The Liver Meeting

Business Wire
·
16 Nov 2024

Analysts Conflicted on These Healthcare Names: Vir Biotechnology (VIR) and Moderna (MRNA)

TIPRANKS
·
06 Nov 2024

Vir Biotechnology Is Maintained at Overweight by Barclays

Dow Jones
·
04 Nov 2024

Vir Biotechnology Price Target Maintained With a $110.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Nov 2024

Analysts Have Lowered Expectations For Vir Biotechnology, Inc. (NASDAQ:VIR) After Its Latest Results

Simply Wall St.
·
04 Nov 2024

Vir Biotechnology price target lowered to $26 from $28 at Barclays

TIPRANKS
·
04 Nov 2024

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Vir Biotechnology (VIR), Cardinal Health (CAH) and Waters (WAT)

TIPRANKS
·
04 Nov 2024

Vir Biotechnology Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.
·
02 Nov 2024

Vir Biotechnology Inc (VIR) Q3 2024 Earnings Call Highlights: Strategic Restructuring and ...

GuruFocus.com
·
02 Nov 2024

Vir Shares Rally 25% on Cancer Licensing Deal With Sanofi, Trial Updates

Dow Jones
·
02 Nov 2024

Bank of America Securities Sticks to Their Hold Rating for Vir Biotechnology (VIR)

TIPRANKS
·
01 Nov 2024

Vir Biotechnology (NASDAQ:VIR) shareholders have endured a 76% loss from investing in the stock three years ago

Simply Wall St.
·
01 Nov 2024

Stock Track | Vir Biotech Soars 5.74% on Analyst Optimism Despite Mixed Earnings

Stock Track
·
01 Nov 2024

Vir Biotechnology Price Target Maintained With a $19.00/Share by Needham

Dow Jones
·
01 Nov 2024